Pharmaceutical

The promising role of GLP-1RAs in NASH

Research has shown that GLP-1RAs may have the potential to treat chronic metabolic diseases such as non-alcoholic steatohepatitis (NASH).

Jun 29, 2023 - 20:00
The promising role of GLP-1RAs in NASH
Research has shown that GLP-1RAs may have the potential to treat chronic metabolic diseases such as non-alcoholic steatohepatitis (NASH).
Read the original article

Tags:

Previous Article

Cellusion shares pipeline update for eye disease stem cell therapy

Next Article

AI with volumetric thresholds facilitate opportunistic screening for splenomegaly

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Lilly’s obesity pill cuts 15% of weight at highest dose in mid-stage trial

STAT+: Lilly’s obesity pill cuts 15% of weight at highe...

Jun 24, 2023

Researchers try to tease out possible ties between long Covid and menopause

Researchers try to tease out possible ties between long...

Oct 20, 2023

Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions

Signal: Porosome files comprehensive patent for therapi...

Aug 22, 2023